Clustering data with hclust algorithm for Plasma metabolomics: Comparison of non-diabetic controls with T1D patients (Study ST000045)

MS negative ion mode/HILIC (Analysis AN000075)
MetaboliteStructureF1F2
SedoheptuloseME6483240.231.12
ThyroaceticacidME6483271.110.40
N-Acetyl-DL-tryptophanME6483161.180.33
2-HydroxyadipicacidME6482671.140.35
Glycine,N-[(3a,5b,7b)-3-hydroxy-24-oxo-7-(sulfooxy)cholan-24-yl-5.922414ME6483011.140.31
2-methyl-tridecanedioicacidME6482701.320.36
Glycine,N-[(3a,5b,7b)-3-hydroxy-24-oxo-7-(sulfooxy)cholan-24-ylME6483001.220.42
IsovalericacidME6483081.230.42
LysArgLeuME6483131.110.50
D-GlucoseME6482931.230.65
MedroxyprogesteroneglucuronideME6483141.220.64
Glutaral(Glutaraldehyde)-1.6054474ME6482981.170.59
Niacin(Nicotinicacid)ME6483191.180.63
VD2716ME6483301.080.59
2-PropylglutaricacidME6482731.110.64
NaringinME6483181.080.69
AsnAsnAsnME6482891.00NA
2-oxocapricacidME6482711.00NA
8,13-dihydroxy-9,11-octadecadienoicacidME6482781.00NA
3-HydroxydodecanedioicacidME6482751.270.05
5C-aglyconeME6482761.310.17
LactaldehydeME6483101.110.78
(E)-2-MethylglutaconicacidME6482631.100.75
QuinolME6483221.110.76
GlutaricacidME6482991.060.80
GemfibrozilME6482961.020.77
AcetoinME6482791.070.75
NaproxenME6483171.050.75
2R-aminoheptanoicacidME6482741.010.98
IdebenoneMetabolite(Benzenebutanoicacid,2,5-dihydroxy-3,4-dimethoxy-6-methyl-)ME6483071.020.97
SulfaphenazoleME6483261.020.96
5-tert-Butyl-4-hydroxymethylfuran-2-carboxylicacidME6482771.040.92
ArgCysGlyME6482871.040.91
19-hydroxy-17-oxoandrost-5-en-3-beta-ylsulfateME6482641.030.94
a-hydroxybutyrateME6482811.050.94
desethyletomidateME6482921.120.91
LeucineME6483111.040.86
2-Hydroxy-4-methylvalericacidME6482661.080.84
Glutaral(Glutaraldehyde)ME6482971.080.85
ArgSerPheME6482881.100.87
GlycoursodeoxycholicacidME6483021.070.88
OctanolME6483200.971.05
AdipicacidME6482800.971.04
a-hydroxyisovalerate-1.511073ME6482830.981.04
ChenodeoxycholyltaurineME6482910.961.06
SpironolactoneME6483250.971.07
2-HydroxyethinylestradiolME6482681.001.00
AminopterinME6482840.981.01
Isovalericacid-2.2218697ME6483090.991.02
a-hydroxyisovalerateME6482820.981.03
DigoxigeninmonodigitoxosideME6482940.991.03
AndrosteroneglucuronideME6482850.921.13
Flecainidemeta-O-dealkylatedME6482950.901.11
PhenolME6483210.971.09
UridineME6483290.931.09
LysArgGlyME6483120.941.07
TrpPheME6483280.951.08
Benzenemethanol,2-(2-aminopropoxy)-3-methyl-ME6482900.761.14
2-OxovalericacidME6482720.851.19
ArgArgLysME6482860.861.15
2-Methoxyestrone3-sulfateME6482690.941.23
HisIleTrpME6483050.901.19
RibothymidineME6483230.921.20
Hydantoin-5-propionicacidME6483060.881.21
MetHisLysME6483150.881.24
2-Hydroxy-3-(4-methoxyethylphenoxy)-propanoicacidME6482650.621.63
GPEtn(16:0/0:0)ME6483030.841.34
(6R)-1alpha,25-dihydroxyvitaminD36,19-sulfurdioxideadduct/(6R)-1alpha,25-dihydroxycholecalcifeME6482620.741.36
GPEtn(18:0/0:0)ME6483040.721.30

Factors:

F1Treatment:Insulin Withdrawal
F2Treatment:Saline Infusion
Data matrix
  logo